Genomic instability and cancer: Networks involved in response to DNA damage

被引:71
作者
Eyfjord, JE [1 ]
Bodvarsdottir, SK
机构
[1] Univ Iceland, Fac Med, Iceland Canc Soc, IS-105 Reykjavik, Iceland
[2] Iceland Canc Soc, Mol & Cell Biol Res Lab, IS-105 Reykjavik, Iceland
关键词
genomic instability; cancer; DNA damage;
D O I
10.1016/j.mrfmmm.2005.05.010
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A new approach to cancer and new methods in examining rare human chromosome breakage syndromes have brought to light complex interactions between different pathways involved in damage response, cell cycle checkpoint control and DNA repair. The genes affected in these different syndromes are involved in networks of processes that respond to DNA damage and prevent chromosomal aberrations during the cell cycle. The genes involved include the ATM, ATR, FA-associated genes, NBS1 and the cancer susceptibility genes BRCA1 and BRCA2. Chromosomal instability is a common feature of many human cancers and most of the instability syndromes, characterized by sensitivity to different types of DNA damage, also show increased cancer susceptibility. Better understanding of these syndromes and their links with familial cancer provide new insight into associations between defects in DNA damage response, cell cycle control, DNA repair and cancer. Understanding the damage response repair networks that these studies are revealing will have important implications for the development of cancer management and treatment. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:18 / 28
页数:11
相关论文
共 75 条
[1]   DNA and telomeres: beginnings and endings [J].
Bailey, SM ;
Goodwin, EH .
CYTOGENETIC AND GENOME RESEARCH, 2004, 104 (1-4) :109-115
[2]   DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation [J].
Bakkenist, CJ ;
Kastan, MB .
NATURE, 2003, 421 (6922) :499-506
[3]  
Bergthorsson JT, 1998, HUM MUTAT, pS195
[4]   Workshop on The Epidemiology of the ATMGene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002 [J].
Jonine L Bernstein ;
Daniela Seminara ;
Anne-Lise Børresen-Dale .
Breast Cancer Research, 4 (6)
[5]  
BIRGISDOTTIR V, 2004, AACR 94 ANN M ORL FL
[6]  
BODVARSDOTTIR SK, 2004, AACR 94 ANN M ORL FL
[7]   Structure of a BRCA1-BARD1 heterodimeric RING-RING complex [J].
Brzovic, PS ;
Rajagopal, P ;
Hoyt, DW ;
King, MC ;
Klevit, RE .
NATURE STRUCTURAL BIOLOGY, 2001, 8 (10) :833-837
[8]   Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia [J].
Callén, E ;
Samper, E ;
Ramírez, MJ ;
Creus, A ;
Marcos, R ;
Ortega, JJ ;
Olivé, T ;
Badell, I ;
Blasco, MA ;
Surrallés, J .
HUMAN MOLECULAR GENETICS, 2002, 11 (04) :439-444
[9]   The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment [J].
Chen, PL ;
Chen, CF ;
Chen, YM ;
Xiao, J ;
Sharp, ZD ;
Lee, WH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) :5287-5292
[10]   Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers [J].
Collins, N ;
Wooster, R ;
Stratton, MR .
BRITISH JOURNAL OF CANCER, 1997, 76 (09) :1150-1156